|
⚲
|
| Keyboard |
| Clarus Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001286162 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001286162] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2022-04-20 | Sell | 2,061,685 | $2.53 | 5,216,063 |
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2022-04-20 | Sell | 5,722 | $2.53 | 14,477 |
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2022-04-20 | Sell | 7,585 | $2.53 | 19,190 |
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2022-04-20 | Sell | 1,164 | $2.53 | 2,945 |
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2022-04-20 | Sell | 13,630 | $2.53 | 34,484 |
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2022-04-20 | Sell | 1,663,126 | $2.53 | 4,207,709 |
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2021-09-09 | Other | 135,000 | $0.00 | |
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2021-09-09 | Option exercise | 1,437,500 | $0.00 | |
|
Clarus Therapeutics Inc CRXT
Warrant · derivative
|
2021-09-09 | Grant | 3,445,000 | $1.00 | 3,445,000 |
|
Clarus Therapeutics Inc CRXT
Class B Common Stock · derivative
|
2021-09-09 | Option exercise | 1,437,500 | $0.00 |